Survival for patients with single and multiple primary melanomas the genes, environment, and melanoma study

JAMA Dermatology

Volumn 149, Issue 8, 2013, Pages 921-927

  Kricker, Anne ^a   Armstrong, Bruce K ^a   Goumas, Chris ^a,b   Thomas, Nancy E ^b   From, Lynn ^c   Busam, Klaus ^d   Kanetsky, Peter A ^e   Gallagher, Richard P ^f   Marrett, Loraine D ^g   Groben, Pamela A ^a   Gruber, Stephen B ^h   Anton Culver, Hoda ⁱ   Rosso, Stefano ^j   Dwyer, Terence ^k,m   Berwick, Marianne ^l  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^g CANCER CARE ONTARIO   (Canada)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j CPO Centre for Epidemiology and Prevention in Oncology in Piedmont   (Italy)

^k ROYAL CHILDREN'S HOSPITAL   (Australia)

^l UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^m INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CANADA; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CHILD; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MITOSIS; MULTIPLE PRIMARY MELANOMA; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCALP TUMOR; SCHOOL CHILD; SINGLE PRIMARY MELANOMA; SKIN ULCER; TUMOR LOCALIZATION; TUMOR VOLUME; UNITED STATES;

EID: 84883163312     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.4581     Document Type: Article

References (25)

1. Murali R, Goumas C, Kricker A, et al GEM Study Group. Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas. Ann Surg Oncol. 2012;19(3):1024-1033.
2. Ferrone CR, Ben Porat L, Panageas KS, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA. 2005;294(13):1647- 1654.
3. Johnson TM, Hamilton T, Lowe L. Multiple primary melanomas. J AmAcad Dermatol. 1998;39(3):422-427.
4. Burden AD, Newell J, Andrew N, Kavanagh G, Connor JM, MacKie RM. Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol. 1999;135(3):261-265.
5. Scheibner A, Milton GW, McCarthy WH, Norlund JJ, Pearson LJ. Multiple primary melanoma: A review of 90 cases. Australas J Dermatol. 1982;23(1):1-8.
6. Savoia P, Quaglino P, Verrone A, Bernengo MG. Multiple primary melanomas: Analysis of 49 cases. Melanoma Res. 1998;8(4):361-366.
7. Slingluff CL Jr, Vollmer RT, Seigler HF. Multiple primary melanoma: Incidence and risk factors in 283 patients. Surgery. 1993;113(3):330-339.
8. Doubrovsky A, Menzies SW. Enhanced survival in patients with multiple primary melanoma. Arch Dermatol. 2003;139(8):1013-1018.
9. Murali R, Brown PT, Kefford RF, et al. Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma. Cancer. 2012;118(18):4519-4529.
10. Hwa C, Price LS, Belitskaya-Levy I, et al. Single versus multiple primary melanomas: Old questions and new answers. Cancer. 2012;118(17):4184-4192.
11. Begg CB, Hummer AJ, Mujumdar U, et al GEM Study Group. A design for cancer case-control studies using only incident cases: Experience with the GEM study of melanoma. Int J Epidemiol. 2006;35(3):756-764.
12. CockburnM, Peng D, Key C. Melanoma. In: Ries LAG, Young JL, Keel GE, Eisner MP, Horner M-JD, eds. Cancer Survival Among Adults: US SEER Program, 1988-2001: Patient and Tumor Characteristics. Bethesda, MD: National Cancer Institute, SEER Program; 2007:93-100. NIH publication 07-6215. SEER Survival Monograph. http://seer.cancer.gov/publications/survival/seer-survival-mono- lowres.pdf. Accessed February 14, 2012.
13. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635-3648.
14. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19(16):3622-3634.
15. BowerMR, Scoggins CR, Martin RC II, et al. Second primary melanomas: Incidence and outcome. Am Surg. 2010;76(7):675-681.
16. Thompson JF, Soong SJ, Balch CM, et al. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: An analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol. 2011;29(16):2199-2205.
17. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199-6206.
18. AzzolaMF, Shaw HM, Thompson JF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: An analysis of 3661 patients from a single center. Cancer. 2003;97(6):1488-1498.
19. Francken AB, Shaw HM, Thompson JF, et al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol. 2004;11(4):426-433.
20. Murali R, Haydu LE, Long GV, et al. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma. Ann Surg Oncol. 2012;19(6):1782-1789.
21. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol. 2008;144(4):515-521.
22. Tseng WH, Martinez SR. Tumor location predicts survival in cutaneous head and neck melanoma. J Surg Res. 2011;167(2):192-198.
23. Pollack LA, Li J, Berkowitz Z, et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol. 2011;65(5)(suppl 1):S78-S86.
24. Balch CM, Soong SJ, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin. 2004;54(3):131-149; quiz 182-184.
25. Lindholm C, Andersson R, DufmatsM, et al; Swedish Melanoma Study Group. Invasive cutaneous malignant melanoma in Sweden, 1990-1999: A prospective, population-based study of survival and prognostic factors. Cancer. 2004;101(9):2067-2078.